Alexandra Kropotova - Sep 19, 2025 Form 4 Insider Report for SAB Biotherapeutics, Inc. (SABS)

Role
CHIEF MEDICAL OFFICER
Signature
Alexandra Kropotova
Stock symbol
SABS
Transactions as of
Sep 19, 2025
Transactions value $
$0
Form type
4
Date filed
9/22/2025, 05:00 PM
Previous filing
Aug 28, 2025
Next filing
Nov 24, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kropotova Alexandra CHIEF MEDICAL OFFICER 777 W 41ST, SUITE 401, MIAMI BEACH Alexandra Kropotova 2025-09-22 0001825323

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SABS Common Stock Tax liability -1.98K -4.18% 45.3K Sep 19, 2025 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of the Issuer's common stock ("Common Stock") withheld to satisfy tax withholding requirements on the vesting of the Issuer's restricted stock units ("RSUs").
F2 Includes 29,340 shares of Common Stock and 15,932 shares of Common Stock which remain subject to vesting of RSUs granted under the Issuer's 2021 Equity Incentive Plan, as amended.
F3 Each RSU represents a contingent right to receive one share of Common Stock.